Human RASAL2/NGAP ORF/cDNA clone-Lentivirus plasmid (NM_170692.2)

Cat. No.: pGMLP005686
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human RASAL2/NGAP Lentiviral expression plasmid for RASAL2 lentivirus packaging, RASAL2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to RASAL2/NGAP products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1837.2
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP005686
Gene Name RASAL2
Accession Number NM_170692.2
Gene ID 9462
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 3843 bp
Gene Alias NGAP
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGAGCTCTCTCCGTCGTCCGGAGGAGCCGCGGAGGCGCTGTCCTGGCCGGAGATGTTCCCGGCGCTGGAGTCCGACTCGCCGCTGCCCCCGGAGGACCTGGACGCGGTTGTCCCAGTCAGTGGAGCCGTCGCCGGTGGCATGTTGGATCGGATCCTTCTGGAGTCCGTGTGCCAGCAACAGAGCTGGGTCCGGGTGTACGATGTGAAAGGACCACCCACCCACCGTCTGTCTTGTGGTCAGTCACCCTACACCGAGACAACAACGTGGGAGCGGAAGTATTGCATCCTCACAGACAGCCAGTTGGTATTGCTCAACAAGGAGAAGGAGATACCTGTGGAAGGGGGACAGGAGCAGCAGACAGATTCCACCAAAGGGCGATGCCTGAGGAGAACTGTCAGTGTCCCTTCCGAGGGTCAGTTTCCCGAGTACCCACCAGAGGGCGCCACTAAACTGGAGGTACCAGCAGAAAGGTCCCCTCGTAGACGGAGTATCTCAGGGACCAGTACATCAGAGAAACCCAACTCCATGGACACTGCAAATACCTCACCCTTCAAAGTACCAGGATTCTTCAGCAAGCGCCTGAAAGGCTCCATCAAGAGGACCAAAAGCCAGTCAAAGCTTGACAGAAACACGAGCTTTCGGCTTCCATCCCTTCGCAGTACAGATGACAGGTCTCGTGGGCTGCCTAAACTAAAAGAGTCACGTTCCCATGAATCCTTGCTGAGCCCATGCAGCACAGTGGAATGTCTGGATCTTGGTAGAGGGGAACCTGTATCAGTGAAACCACTTCATAGTAGCATCCTTGGACAAGACTTCTGCTTTGAGGTTACCTACTTAAGTGGAAGTAAATGCTTCAGCTGTAATTCTGCTTCTGAGAGAGACAAGTGGATGGAAAACCTTCGCAGGACAGTTCAACCTAATAAGGACAATTGCAGGCGAGCTGAAAATGTTCTTCGTTTATGGATCATTGAAGCCAAGGACCTTGCCCCTAAAAAGAAATATTTCTGCGAACTGTGCCTTGATGATACCCTCTTTGCTCGTACAACCAGCAAGACCAAAGCAGACAATATTTTCTGGGGCGAACATTTTGAATTCTTCAGCCTTCCACCTCTTCATAGTATCACAGTTCACATTTACAAGGATGTGGAAAAAAAGAAAAAAAAGGACAAGAATAATTATGTAGGGCTAGTCAACATCCCCACTGCCAGTGTGACTGGTCGCCAATTTGTAGAAAAGTGGTATCCAGTGAGTACACCTACACCCAACAAAGGAAAGACAGGAGGACCTTCTATTCGGATTAAATCACGTTTCCAAACTATCACCATTCTGCCTATGGAGCAATACAAAGAATTTGCAGAATTTGTCACCAGCAACTACACCATGCTGTGTTCTGTCCTTGAGCCAGTAATTAGTGTGAGAAATAAAGAGGAGTTGGCTTGTGCCTTAGTGCACATTCTTCAAAGTACTGGCAGAGCCAAGGATTTTCTGACTGACTTGGTGATGTCTGAGGTGGATCGTTGTGGAGAGCATGATGTCTTGATCTTCAGAGAGAACACTATTGCCACCAAATCCATTGAGGAATACCTCAAGTTGGTGGGACAACAGTATCTTCATGACGCACTGGGGGAGTTTATCAAAGCTTTGTATGAGTCCGATGAGAACTGTGAAGTGGATCCCAGCAAATGTTCATCTAGTGAACTGATAGACCATCAGAGCAACCTGAAAATGTGCTGTGAGCTGGCTTTCTGCAAGATCATCAACTCTTACTGTGTTTTCCCTCGTGAGTTGAAAGAAGTGTTTGCATCATGGAAGCAGCAGTGCCTGAACCGTGGCAAGCAAGACATCAGCGAGAGGCTCATCAGTGCCTCATTATTTCTCCGTTTTCTGTGTCCAGCCATTATGTCTCCCAGTCTTTTCAACCTTATGCAGGAGTATCCTGATGACCGCACATCTCGGACTCTAACTCTTATTGCCAAGGTCATTCAGAACCTGGCCAACTTTGCCAAGTTTGGTAACAAAGAGGAATACATGGCATTCATGAATGATTTTTTAGAACATGAATGGGGTGGAATGAAGCGCTTTCTTTTGGAGATCTCTAATCCAGACACCATCTCAAACACCCCAGGCTTTGATGGTTACATTGATCTGGGCCGAGAGCTTTCAGTTTTGCATTCCTTACTGTGGGAAGTAGTTTCCCAACTTGATAAGGCGACCGTGGCAAAATTGGGGCCTCTCCCTCGTGTTCTTGCTGATATTACCAAGTCATTGACTAATCCTACGCCAATACAACAGCAACTGAGACGCTTCACTGAACATAACTCCAGTCCAAATGTCAGTGGAAGCCTCTCCTCTGGGCTGCAGAAAATATTTGAAGACCCCACTGACAGTGATTTGCATAAACTAAAATCTCCAAGCCAGGACAACACAGACAGCTACTTCAGAGGGAAAACATTATTGCTGGTTCAGCAAGCCTCCTCTCAGAGCATGACTTATTCTGAAAAGGATGAAAGGGAAAGTAGCCTTCCTAATGGTCGGAGCGTCTCCCTCATGGACCTCCAGGACACTCATGCTGCTCAAGTGGAGCATGCATCTGTCATGCTTGATGTGCCTATACGCTTGACCGGAAGCCAGCTTTCCATAACCCAGGTGGCCAGCATCAAACAGCTGCGGGAAACCCAGAGCACTCCCCAAAGTGCACCCCAAGTGAGAAGGCCCCTGCACCCAGCCTTGAACCAGCCAGGTGGCCTTCAGCCCTTGTCGTTCCAGAACCCTGTCTATCACCTCAATAACCCAATTCCAGCAATGCCAAAGGCCTCTATAGATTCCAGTTTGGAGAACCTAAGCACTGCCAGTTCCAGAAGCCAAAGTAACAGTGAAGACTTCAAGCTCAGTGGACCCAGCAATAGCAGCATGGAAGATTTCACTAAACGTAGCACTCAGAGTGAGGACTTCTCCAGGCGGCACACGGTGCCAGATAGACACATACCTCTTGCTTTGCCACGACAAAATAGTACTGGGCAGGCCCAGATCCGAAAAGTGGACCAGGGTGGGTTAGGTGCCCGAGCCAAAGCCCCACCATCCCTGCCACACAGTGCTTCTTTACGTAGCACCGGGAGCATGTCAGTGGTGTCCGCAGCCCTGGTGGCCGAACCTGTGCAGAATGGGAGCCGGTCCCGGCAGCAGTCCTCTTCCTCCAGAGAGAGCCCTGTTCCCAAAGTTAGAGCAATCCAGAGACAACAGACACAGCAGGTTCAGTCACCTGTGGACTCTGCCACAATGTCCCCAGTAGAGAGGACAGCAGCCTGGGTTCTGAACAATGGGCAGTATGAAGAGGATGTGGAAGAAACTGAGCAAAATCTAGATGAAGCCAAGCATGCTGAGAAGTATGAACAAGAAATTACTAAACTGAAGGAGCGCCTGAGAGTTTCCAGCCGGCGACTGGAGGAATATGAACGCCGCTTGCTGGTGCAGGAGCAGCAGATGCAGAAGCTGCTGCTGGAATACAAGGCCCGACTGGAGGACAGCGAGGAGCGGCTCCGAAGACAGCAGGAAGAAAAAGATAGCCAGATGAAAAGCATCATCAGCAGGCTAATGGCTGTGGAAGAGGAACTGAAGAAGGATCATGCTGAGATGCAAGCAGTTATTGATGCAAAGCAGAAAATAATTGATGCACAGGAAAAACGGATCGTGTCCCTGGATTCAGCCAACACCAGACTGATGAGCGCGCTGACCCAAGTGAAGGAGCGGTACAGCATGCAGGTCCGCAATGGCATCTCCCCCACCAACCCCACCAAGCTTTCCATCACGGAGAATGGTGAATTCAAAAACAGCAGCTGCTGA
ORF Protein Sequence MELSPSSGGAAEALSWPEMFPALESDSPLPPEDLDAVVPVSGAVAGGMLDRILLESVCQQQSWVRVYDVKGPPTHRLSCGQSPYTETTTWERKYCILTDSQLVLLNKEKEIPVEGGQEQQTDSTKGRCLRRTVSVPSEGQFPEYPPEGATKLEVPAERSPRRRSISGTSTSEKPNSMDTANTSPFKVPGFFSKRLKGSIKRTKSQSKLDRNTSFRLPSLRSTDDRSRGLPKLKESRSHESLLSPCSTVECLDLGRGEPVSVKPLHSSILGQDFCFEVTYLSGSKCFSCNSASERDKWMENLRRTVQPNKDNCRRAENVLRLWIIEAKDLAPKKKYFCELCLDDTLFARTTSKTKADNIFWGEHFEFFSLPPLHSITVHIYKDVEKKKKKDKNNYVGLVNIPTASVTGRQFVEKWYPVSTPTPNKGKTGGPSIRIKSRFQTITILPMEQYKEFAEFVTSNYTMLCSVLEPVISVRNKEELACALVHILQSTGRAKDFLTDLVMSEVDRCGEHDVLIFRENTIATKSIEEYLKLVGQQYLHDALGEFIKALYESDENCEVDPSKCSSSELIDHQSNLKMCCELAFCKIINSYCVFPRELKEVFASWKQQCLNRGKQDISERLISASLFLRFLCPAIMSPSLFNLMQEYPDDRTSRTLTLIAKVIQNLANFAKFGNKEEYMAFMNDFLEHEWGGMKRFLLEISNPDTISNTPGFDGYIDLGRELSVLHSLLWEVVSQLDKATVAKLGPLPRVLADITKSLTNPTPIQQQLRRFTEHNSSPNVSGSLSSGLQKIFEDPTDSDLHKLKSPSQDNTDSYFRGKTLLLVQQASSQSMTYSEKDERESSLPNGRSVSLMDLQDTHAAQVEHASVMLDVPIRLTGSQLSITQVASIKQLRETQSTPQSAPQVRRPLHPALNQPGGLQPLSFQNPVYHLNNPIPAMPKASIDSSLENLSTASSRSQSNSEDFKLSGPSNSSMEDFTKRSTQSEDFSRRHTVPDRHIPLALPRQNSTGQAQIRKVDQGGLGARAKAPPSLPHSASLRSTGSMSVVSAALVAEPVQNGSRSRQQSSSSRESPVPKVRAIQRQQTQQVQSPVDSATMSPVERTAAWVLNNGQYEEDVEETEQNLDEAKHAEKYEQEITKLKERLRVSSRRLEEYERRLLVQEQQMQKLLLEYKARLEDSEERLRRQQEEKDSQMKSIISRLMAVEEELKKDHAEMQAVIDAKQKIIDAQEKRIVSLDSANTRLMSALTQVKERYSMQVRNGISPTNPTKLSITENGEFKNSSC

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP2692-Ab Anti-RASAL2 monoclonal antibody
    Target Antigen GM-Tg-g-IP2692-Ag RASAL2 protein
    ORF Viral Vector pGMLP005686 Human RASAL2 Lentivirus plasmid
    ORF Viral Vector vGMLP005686 Human RASAL2 Lentivirus particle


    Target information

    Target ID GM-IP2692
    Target Name RASAL2
    Gene ID 9462, 226525, 718958, 304893, 101100534, 480056, 540692, 100033986
    Gene Symbol and Synonyms 6530401P13,A330066M24Rik,NGAP,RASAL2
    Uniprot Accession Q9UJF2
    Uniprot Entry Name NGAP_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000075391
    Target Classification Not Available

    This gene encodes a protein that contains the GAP-related domain (GRD), a characteristic domain of GTPase-activating proteins (GAPs). GAPs function as activators of Ras superfamily of small GTPases. The protein encoded by this gene is able to complement the defective RasGAP function in a yeast system. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.